Loading
Latest filing published 27 Sept 2021 for CytoDyn Inc., €341k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Jordan G. Naydenov on record concern CytoDyn Inc., in the capacity of board member. We count 22 filings; the first trade dates from 1 July 2009 and the latest from 23 September 2021.
No open-market sale appears; the market trades are 3 purchases worth €897k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 12 share grants and 5 option exercises.
A typical purchase (the median) is worth €252k.
The newest entry dates from 27 September 2021: an option exercise of €85k, in CytoDyn Inc. The last insider purchase was made public on 3 November 2020, 2,181 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration